Is Foundayo Safe Long Term? What The Clinical Trial Data Actually Shows
Foundayo (orforglipron) represents the first oral GLP-1 receptor agonist approved for type 2 diabetes, offering patients an alternative to daily…
April 3, 2026
5 min read